These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29778550)

  • 41. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
    Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
    BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk.
    Sroczynski G; Hallsson LR; Mühlberger N; Jahn B; Rehms R; Hoffmann S; Crispin A; Lindoerfer D; Mansmann U; Siebert U
    Int J Cancer; 2024 Feb; 154(3):516-529. PubMed ID: 37795630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012.
    Redwood D; Provost E; Asay E; Roberts D; Haverkamp D; Perdue D; Bruce MG; Sacco F; Espey D
    Prev Chronic Dis; 2014 Apr; 11():E56. PubMed ID: 24721216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Accuracy of immunochemical faecal occult blood test for colorectal cancer: meta-analysis].
    Jiang Y; Liu G; Huang H; Huang W; Zhang X; Fu W; Dai M; Shi J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 May; 49(5):392-8. PubMed ID: 26081701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.
    Longstreth GF; Anderson DS; Zisook DS; Shi JM; Lin JC
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2929-2936.e1. PubMed ID: 32007541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
    Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
    BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Relationship between the Methylated Septin-9 DNA Blood Test and Stool Occult Blood Test for Diagnosing Colorectal Cancer in Taiwanese People.
    Chen CH; Yan SL; Yang TH; Chen SF; Yeh YH; Ou JJ; Lin CH; Lee YT; Chen CH
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27390118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
    Yang H; Ge Z; Dai J; Li X; Gao Y
    Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
    Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
    Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
    Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 56. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.
    Brenner H; Calderazzo S; Seufferlein T; Ludwig L; Dikopoulos N; Mangold J; Böck W; Stolz T; Eisenbach T; Block T; Kopp-Schneider A; Czock D; Tikk K
    JAMA; 2019 May; 321(17):1686-1692. PubMed ID: 31063574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
    Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.